EXC vs. CPRX
EXC (Exelon Corporation) and CPRX (Catalyst Pharmaceuticals, Inc.) are both stocks. EXC operates in Utilities - Diversified (Utilities), while CPRX operates in Biotechnology (Healthcare). Over the past 10 years, EXC returned 10.63%/yr vs 46.26%/yr for CPRX. At a 0.11 correlation, their price movements are largely independent.
Performance
EXC vs. CPRX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EXC achieves a 7.92% return, which is significantly lower than CPRX's 34.36% return. Over the past 10 years, EXC has underperformed CPRX with an annualized return of 10.63%, while CPRX has yielded a comparatively higher 46.26% annualized return.
EXC
- 1D
- 1.54%
- 1M
- 7.53%
- YTD
- 7.92%
- 6M
- 7.97%
- 1Y
- 10.70%
- 3Y*
- 9.48%
- 5Y*
- 10.71%
- 10Y*
- 10.63%
CPRX
- 1D
- -0.03%
- 1M
- 0.58%
- YTD
- 34.36%
- 6M
- 32.77%
- 1Y
- 33.28%
- 3Y*
- 39.03%
- 5Y*
- 40.44%
- 10Y*
- 46.26%
EXC vs. CPRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
EXC Exelon Corporation | 7.92% | 20.02% | 10.29% | -13.96% | 8.29% | 41.48% | -3.87% | 4.27% | 18.33% | 15.08% |
CPRX Catalyst Pharmaceuticals, Inc. | 34.36% | 11.84% | 24.15% | -9.62% | 174.74% | 102.69% | -10.93% | 95.31% | -50.90% | 272.38% |
Correlation
The correlation between EXC and CPRX is 0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.02 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 8, 2006 | 0.11 |
The correlation between EXC and CPRX shifts across timeframes, from 0.02 (1 year) to 0.15 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
EXC:
$47.41B
CPRX:
$3.98B
EXC:
$2.74
CPRX:
$1.74
EXC:
16.85
CPRX:
18.02
EXC:
1.37
CPRX:
0.32
EXC:
1.89
CPRX:
6.68
EXC:
1.62
CPRX:
3.93
EXC:
$24.79B
CPRX:
$596.96M
EXC:
$7.32B
CPRX:
$378.23M
EXC:
$7.82B
CPRX:
$313.50M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EXC vs. CPRX — Risk / Return Rank
EXC
CPRX
EXC vs. CPRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Exelon Corporation (EXC) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| EXC | CPRX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.35 | ||
| Sortino ratioReturn per unit of downside risk | -0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.18 | -0.08 |
| Calmar ratioReturn relative to maximum drawdown | 0.71 | 1.52 | -0.81 |
| Martin ratioReturn relative to average drawdown | 1.72 | 3.46 | -1.74 |
Loading charts...
Drawdowns
EXC vs. CPRX - Drawdown Comparison
The maximum EXC drawdown since its inception was -62.27%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for EXC and CPRX.
Loading charts...
Drawdown Indicators
| EXC | CPRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -62.27% | -94.25% | +31.98% |
Max Drawdown (1Y)Largest decline over 1 year | -13.74% | -19.18% | +5.44% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -27.29% | +6.55% |
Max Drawdown (5Y)Largest decline over 5 years | -29.06% | -45.37% | +16.31% |
Max Drawdown (10Y)Largest decline over 10 years | -40.04% | -64.87% | +24.83% |
Current DrawdownCurrent decline from peak | -7.25% | -0.03% | -7.22% |
Average DrawdownAverage peak-to-trough decline | -20.04% | -51.96% | +31.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.67% | 9.84% | -4.17% |
Volatility
EXC vs. CPRX - Volatility Comparison
Exelon Corporation (EXC) has a higher volatility of 6.04% compared to Catalyst Pharmaceuticals, Inc. (CPRX) at 0.47%. This indicates that EXC's price experiences larger fluctuations and is considered to be riskier than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EXC | CPRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.04% | 0.47% | +5.57% |
Volatility (6M)Calculated over the trailing 6-month period | 14.37% | 23.17% | -8.80% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.32% | 33.28% | -14.96% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.68% | 47.77% | -27.09% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.94% | 60.39% | -36.45% |
Dividends
EXC vs. CPRX - Dividend Comparison
EXC's dividend yield for the trailing twelve months is around 3.55%, while CPRX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EXC Exelon Corporation | 3.55% | 3.67% | 5.05% | 4.01% | 3.12% | 2.65% | 3.62% | 3.18% | 3.06% | 3.32% | 3.56% | 4.47% |
Financials
EXC vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Exelon Corporation and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EXC vs. CPRX - Profitability Comparison
EXC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Exelon Corporation reported a gross profit of 3.39B and revenue of 7.24B. Therefore, the gross margin over that period was 46.9%.
CPRX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a gross profit of 0.00 and revenue of 149.39M. Therefore, the gross margin over that period was 0.0%.
EXC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Exelon Corporation reported an operating income of 1.61B and revenue of 7.24B, resulting in an operating margin of 22.2%.
CPRX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported an operating income of 73.23M and revenue of 149.39M, resulting in an operating margin of 49.0%.
EXC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Exelon Corporation reported a net income of 919.00M and revenue of 7.24B, resulting in a net margin of 12.7%.
CPRX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Catalyst Pharmaceuticals, Inc. reported a net income of 63.73M and revenue of 149.39M, resulting in a net margin of 42.7%.
Frequently Asked Questions
EXC and CPRX have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
EXC has higher volatility (6.04%) compared to CPRX (0.47%). In terms of maximum drawdown, EXC dropped -62.27% vs CPRX's -94.25%.
CPRX currently has the higher Sharpe Ratio (0.89 vs 0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EXC and CPRX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer